HIV & AIDS

Plant-based compound may inhibit HIV

A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.

HIV & AIDS

Political strife undermines HIV treatment

As Kenyan citizens negotiated the tensions following the March 4 nationwide elections, memories of the violence that followed the December 2007 vote weighed heavily for many reasons. Among those in any nation with an HIV ...

HIV & AIDS

In Ethiopia, HIV disclosure is low

In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive ...

HIV & AIDS

New UN AIDS deputy hails Brazil progress

The newly appointed deputy chief of the United Nations HIV-fighting program, Brazilian Luiz Loures, hailed his own country's achievements in the fight against the deadly global epidemic in an interview published Saturday.

HIV & AIDS

Scientists investigate genetics of HIV-1 resistance

Investigating the genetic footprint that drug resistance causes in HIV, researchers in Europe have discovered that compensatory polymorphisms enable resistant viruses to survive. Presented in the journal Retrovirology, the ...

HIV & AIDS

The genetics of HIV-1 resistance

Drug resistance is a major problem when treating infections. This problem is multiplied when the infection, like HIV-1, is chronic. New research published in BioMed Central's open access journal Retrovirology has examined ...

Diseases, Conditions, Syndromes

Trial signals major milestone in hunt for new TB drugs

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...

page 5 from 9